Sort   by:  
 Page size 
UnknownEffect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Not available
S-EPMC9385587 | biostudies-literature
UnknownImpact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Not available
S-EPMC8217989 | biostudies-literature
UnknownEffectiveness of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study.
Not available
S-EPMC7604981 | biostudies-literature
UnknownLong-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Not available
S-EPMC11219688 | biostudies-literature
UnknownInflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Not available
S-EPMC8135208 | biostudies-literature
UnknownDiagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group.
Not available
S-EPMC11941534 | biostudies-literature
UnknownSignificance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Not available
S-EPMC10918499 | biostudies-literature
Sort   by:  
 Page size